Wall Street’s Key Stock Analysts Research Report, All Buys

Wall Street’s Key Stock Analysts Research Report, All Buys

$ARNA, $CHH, $CODX, $NVAX, $PANW

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy

Below is our list for Tuesday, 19 May, as follows:

Arena Pharmaceuticals Inc. (NASDAQ:ARNA) was started with a Buy rating and a 62 price target at Jefferies.

Choice Hotels International Inc. (NASDAQ:CHH) was raised to Buy from Neutral with an 85 price target at Longbow Research.

Co-Diagnostics Inc. (NASDAQ:CODX) was reiterated as Buy and the price target was raised to 35 from 20 at HC Wainwright.

Novavax Inc. (NASDAQ:NVAX) was reiterated as Buy and its price target was raised to 53 from 42 at B Riley FBR.

Palo Alto Networks Inc. (NYSE:PANW) was reiterated as Buy and its price target was raised to 250 from 220 at SunTrust Robinson Humphrey.

Have a healthy day, Keep the Faith!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge. Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.